Integrated Wealth Concepts’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.75M Sell
25,417
-1,295
-5% -$89.4K 0.02% 662
2025
Q1
$1.85M Buy
26,712
+1,630
+6% +$113K 0.02% 596
2024
Q4
$2.16M Sell
25,082
-7,945
-24% -$683K 0.03% 532
2024
Q3
$3.93M Buy
33,027
+477
+1% +$56.8K 0.05% 343
2024
Q2
$4.65M Sell
32,550
-757
-2% -$108K 0.06% 275
2024
Q1
$4.28M Buy
33,307
+8,569
+35% +$1.1M 0.06% 297
2023
Q4
$2.56M Sell
24,738
-603
-2% -$62.4K 0.04% 397
2023
Q3
$2.3M Buy
25,341
+7,331
+41% +$667K 0.04% 406
2023
Q2
$1.46M Buy
18,010
+4,856
+37% +$393K 0.03% 557
2023
Q1
$1.05M Sell
13,154
-43,154
-77% -$3.43M 0.02% 598
2022
Q4
$3.81M Buy
56,308
+674
+1% +$45.6K 0.1% 194
2022
Q3
$2.77M Buy
55,634
+658
+1% +$32.8K 0.09% 214
2022
Q2
$3.06M Buy
54,976
+1,730
+3% +$96.4K 0.1% 197
2022
Q1
$2.96M Buy
53,246
+2,990
+6% +$166K 0.09% 197
2021
Q4
$2.81M Buy
50,256
+4,298
+9% +$241K 0.08% 206
2021
Q3
$2.21M Buy
45,958
+1,838
+4% +$88.2K 0.07% 230
2021
Q2
$1.85M Buy
44,120
+3,862
+10% +$162K 0.07% 232
2021
Q1
$1.36M Buy
40,258
+3,284
+9% +$111K 0.06% 244
2020
Q4
$1.29M Buy
36,974
+3,382
+10% +$118K 0.06% 207
2020
Q3
$1.17M Sell
33,592
-532
-2% -$18.5K 0.07% 188
2020
Q2
$1.12M Buy
34,124
+3,876
+13% +$127K 0.08% 157
2020
Q1
$910K Buy
30,248
+1,780
+6% +$53.6K 0.08% 148
2019
Q4
$824K Buy
28,468
+9,620
+51% +$278K 0.07% 179
2019
Q3
$487K Buy
18,848
+7,496
+66% +$194K 0.05% 212
2019
Q2
$293K Buy
+11,352
New +$293K 0.04% 279